Biller Scott 4
4 · Foghorn Therapeutics Inc. · Filed Jun 25, 2026
Research Summary
AI-generated summary of this filing
Foghorn (FHTX) Director Scott Biller Receives 28,000-Share Award
What Happened
Scott Biller, a director of Foghorn Therapeutics, was granted a derivative award on 2026-06-24 that covers 28,000 shares with a strike/equivalent price of $4.08 per share, representing a notional value of $114,240. This filing records the grant (award/acquisition of a derivative) rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-24; Form 4 filed: 2026-06-25 (timely filing).
- Award: 28,000 derivative shares at $4.08 per share; total notional value $114,240.
- Type: Derivative grant (option award) — not an immediate stock purchase or sale.
- Vesting: Per footnote F1, the option vests in full on the first anniversary of the grant date, subject to continued board service.
- Shares owned after transaction: not specified in the provided excerpt.
Context
This was an option/award grant to a board member, which becomes exercisable only after vesting (one year subject to service). Because it is a derivative grant (not an open-market buy or sale), it does not reflect an immediate transfer of common shares or a cash transaction. Grants to directors are common compensation practices and are reported to show potential future insider ownership.
Insider Transaction Report
- Award
Stock Options (Right to buy)
[F1]2026-06-24$4.08/sh+28,000$114,240→ 28,000 totalExercise: $4.08Exp: 2036-06-23→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors.